# WhitePeach Beta Testing Program Terms of Service and License Agreement

**IMPORTANT NOTICE: BY PARTICIPATING IN THE WHITEPEACH BETA TESTING PROGRAM, YOU ACKNOWLEDGE THAT YOU HAVE READ, UNDERSTOOD, AND AGREE TO BE BOUND BY ALL TERMS AND CONDITIONS SET FORTH IN THIS AGREEMENT.**

## 1. DEFINITIONS AND INTERPRETATION

**1.1 Definitions.** For the purposes of this Agreement, the following terms shall have the meanings set forth below:

- "Agreement" means these Beta Testing Terms of Service and License Agreement, as may be amended from time to time in accordance with Section 15 hereof.
- "Beta Content" means any and all software, applications, code, documentation, specifications, designs, concepts, features, functionality, user interfaces, graphics, audio, video, text, data, and any other materials, information, or content provided by Company in connection with the Beta Testing Program.
- "Beta Testing Program" means the pre-release testing program operated by Company for the purpose of evaluating and improving the Software prior to public release.
- "Company" means WhitePeach and its affiliates, subsidiaries, successors, and assigns.
- "Confidential Information" means all Beta Content and any other non-public, proprietary, or confidential information disclosed by Company to Participant.
- "Participant" means the individual who has been granted access to participate in the Beta Testing Program.
- "Software" means the WhitePeach software application and related services being developed by Company.

**1.2 Interpretation.** The headings in this Agreement are for convenience only and shall not affect the interpretation of this Agreement. Unless the context clearly requires otherwise, references to the singular include the plural and vice versa.

## 2. GRANT OF LICENSE AND SCOPE OF PARTICIPATION

**2.1 Limited License.** Subject to the terms and conditions of this Agreement, Company hereby grants to Participant a limited, non-exclusive, non-transferable, revocable license to access and use the Beta Content solely for the purpose of testing and evaluating the Software and providing feedback to Company.

**2.2 Restrictions.** Participant shall not, and shall not permit any third party to: (a) copy, modify, adapt, alter, translate, or create derivative works of the Beta Content; (b) reverse engineer, disassemble, decompile, or otherwise attempt to derive the source code of the Software; (c) distribute, sell, lease, rent, loan, or otherwise transfer the Beta Content to any third party; (d) use the Beta Content for any commercial purpose or in any manner that competes with Company's business; or (e) remove, alter, or obscure any proprietary notices on the Beta Content.

**2.3 Reservation of Rights.** Company reserves all rights not expressly granted to Participant in this Agreement. No other rights or licenses are granted by implication, estoppel, or otherwise.

## 3. CONFIDENTIALITY AND NON-DISCLOSURE OBLIGATIONS

**3.1 Confidentiality Covenant.** Participant acknowledges that all Confidential Information constitutes valuable trade secrets and proprietary information of Company. Participant agrees to hold all Confidential Information in strict confidence and not to disclose, publish, or disseminate any Confidential Information to any third party without the prior written consent of Company.

**3.2 Standard of Care.** Participant shall use the same degree of care to protect Confidential Information as it uses to protect its own confidential information, but in no event less than reasonable care.

**3.3 Permitted Disclosures.** The obligations set forth in this Section 3 shall not apply to information that: (a) is or becomes publicly available through no breach of this Agreement by Participant; (b) is rightfully received by Participant from a third party without breach of any confidentiality obligation; (c) is independently developed by Participant without use of or reference to Confidential Information; or (d) is required to be disclosed by law or court order, provided that Participant gives Company reasonable advance notice of such requirement.

**3.4 Injunctive Relief.** Participant acknowledges that any breach of this Section 3 would cause irreparable harm to Company for which monetary damages would be inadequate. Therefore, Company shall be entitled to seek injunctive relief and other equitable remedies to prevent or remedy any breach of this Section 3.

## 4. FEEDBACK AND INTELLECTUAL PROPERTY

**4.1 Feedback License.** Participant hereby grants to Company a perpetual, irrevocable, worldwide, royalty-free, non-exclusive license to use, reproduce, modify, distribute, and create derivative works based upon any feedback, suggestions, ideas, or recommendations provided by Participant regarding the Software or Beta Content ("Feedback").

**4.2 Ownership.** Company retains all right, title, and interest in and to the Software, Beta Content, and any modifications or derivative works thereof. Participant acknowledges that no title to or ownership of the Software or Beta Content is transferred to Participant.

**4.3 Moral Rights Waiver.** To the extent permitted by applicable law, Participant hereby waives all moral rights, including without limitation the right to identification and the right to object to derogatory treatment, in connection with any Feedback provided hereunder.

## 5. DATA COLLECTION AND PRIVACY

**5.1 Data Collection.** Company may collect certain data and information about Participant's use of the Software, including but not limited to usage statistics, performance metrics, crash reports, and other diagnostic information ("Usage Data").

**5.2 Privacy Policy.** Company's collection, use, and disclosure of personal information is governed by Company's Privacy Policy, which is incorporated herein by reference.

**5.3 Consent to Data Processing.** By participating in the Beta Testing Program, Participant consents to Company's collection, processing, and use of Usage Data for the purposes of improving the Software and Company's services.

## 6. DISCLAIMERS AND LIMITATIONS

**6.1 AS-IS BASIS.** THE SOFTWARE AND BETA CONTENT ARE PROVIDED "AS IS" AND "AS AVAILABLE" WITHOUT WARRANTIES OF ANY KIND, WHETHER EXPRESS OR IMPLIED. COMPANY DISCLAIMS ALL WARRANTIES, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, AND TITLE.

**6.2 Beta Nature.** Participant acknowledges that the Software is in beta testing phase and may contain bugs, errors, or other issues that could cause system failures or data loss. Participant uses the Software at their own risk.

**6.3 No Service Level Agreement.** Company makes no commitment regarding the availability, uptime, or performance of the Software during the Beta Testing Program.

## 7. LIMITATION OF LIABILITY

**7.1 Exclusion of Damages.** IN NO EVENT SHALL COMPANY BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, INCLUDING BUT NOT LIMITED TO LOSS OF PROFITS, DATA, OR BUSINESS INTERRUPTION, ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT OR THE USE OF THE SOFTWARE, REGARDLESS OF THE THEORY OF LIABILITY AND EVEN IF COMPANY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

**7.2 Limitation of Liability.** COMPANY SHALL HAVE NO LIABILITY WHATSOEVER ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT, REGARDLESS OF THE NATURE OF THE CLAIM OR THE AMOUNT OF DAMAGES ALLEGED.

**7.3 Basis of Bargain.** THE LIMITATIONS SET FORTH IN THIS SECTION 7 REFLECT THE ALLOCATION OF RISK BETWEEN THE PARTIES AND ARE A FUNDAMENTAL ELEMENT OF THE BASIS OF THE BARGAIN BETWEEN THE PARTIES.

## 8. INDEMNIFICATION

Participant agrees to indemnify, defend, and hold harmless Company and its officers, directors, employees, agents, and affiliates from and against any and all claims, liabilities, damages, losses, costs, and expenses (including reasonable attorneys' fees) arising out of or in connection with: (a) Participant's use of the Software or Beta Content; (b) Participant's breach of this Agreement; or (c) Participant's violation of any applicable law or regulation.

## 9. TERMINATION

**9.1 Termination by Company.** Company may terminate this Agreement and Participant's access to the Beta Testing Program at any time, with or without cause, upon notice to Participant.

**9.2 Termination by Participant.** Participant may terminate this Agreement at any time by discontinuing use of the Software and providing written notice to Company.

**9.3 Effect of Termination.** Upon termination of this Agreement: (a) all licenses granted hereunder shall immediately cease; (b) Participant shall immediately cease all use of the Software and Beta Content; (c) Participant shall return or destroy all copies of Confidential Information in their possession or control; and (d) the provisions of Sections 3, 4, 6, 7, 8, and 10 through 16 shall survive.

## 10. DISPUTE RESOLUTION AND APPEALS

**10.1 Informal Resolution.** Prior to initiating formal dispute resolution procedures, the parties agree to attempt to resolve any dispute through good faith negotiations.

**10.2 Appeals Process.** If Participant believes their beta testing access was terminated unfairly, Participant may appeal such decision by contacting Company's designated representative (Discord user ID: 1005856471122198558, username: "neurologists") within thirty (30) days of termination.

**10.3 Arbitration.** Any dispute arising out of or relating to this Agreement that cannot be resolved through informal negotiations shall be resolved through binding arbitration in accordance with the rules of the American Arbitration Association.

## 11. EXPORT CONTROL

Participant acknowledges that the Software may be subject to export control laws and regulations. Participant agrees to comply with all applicable export control laws and regulations and not to export, re-export, or transfer the Software to any prohibited country, entity, or individual.

## 12. FORCE MAJEURE

Neither party shall be liable for any failure or delay in performance under this Agreement due to circumstances beyond its reasonable control, including but not limited to acts of God, natural disasters, war, terrorism, labor disputes, or government actions.

## 13. SEVERABILITY

If any provision of this Agreement is held to be invalid, illegal, or unenforceable, the remaining provisions shall continue in full force and effect, and the invalid provision shall be modified to the minimum extent necessary to make it valid and enforceable.

## 14. ENTIRE AGREEMENT

This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, understandings, and communications, whether written or oral.

## 15. AMENDMENTS

Company may modify this Agreement at any time by posting the revised terms. Participant's continued participation in the Beta Testing Program after such posting constitutes acceptance of the revised terms.

## 16. GOVERNING LAW

This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to its conflict of laws principles.

## 17. VOLUNTARY PARTICIPATION

**17.1 No Obligation.** Participant's participation in the Beta Testing Program is entirely voluntary. Participant may withdraw from the Beta Testing Program at any time without penalty.

**17.2 No Employment Relationship.** Nothing in this Agreement creates an employment, agency, partnership, or joint venture relationship between the parties.

## 18. CONTACT INFORMATION

For questions regarding this Agreement or the Beta Testing Program, please contact Company through the designated beta testing channels or reach out to the development team.

---

**PARTICIPANT ACKNOWLEDGMENT:** BY PARTICIPATING IN THE BETA TESTING PROGRAM, PARTICIPANT ACKNOWLEDGES THAT THEY HAVE READ, UNDERSTOOD, AND AGREE TO BE BOUND BY ALL TERMS AND CONDITIONS OF THIS AGREEMENT.

*Last Updated: July 9, 2025*

*© 2025 WhitePeach. All rights reserved.*
